| # | Drug | Count |
|---|---|---|
| 0 | FILGRASTIM | 5 |
| 1 | ADALIMUMAB | 4 |
| 2 | ADALIMUMAB-AATY | 4 |
| 3 | ADALIMUMAB-ADAZ | 4 |
| 4 | ADALIMUMAB-FKJP | 4 |
| 5 | ALEMTUZUMAB | 4 |
| 6 | ANAKINRA | 4 |
| 7 | CANAKINUMAB | 4 |
| 8 | CYCLOSPORINE | 4 |
| 9 | ETANERCEPT | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 4 | 0.0014 |
| 1 | THIOTEPA | 4 | 0.0004 |
| 2 | CANAKINUMAB | 4 | 0.0004 |
| 3 | GOLIMUMAB | 4 | 0.0003 |
| 4 | ANAKINRA | 4 | 0.0002 |
| 5 | ALEMTUZUMAB | 4 | 0.0002 |
| 6 | FILGRASTIM | 5 | 0.0001 |
| 7 | FLUDARABINE PHOSPHATE | 4 | 0.0001 |
| 8 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| 9 | ADALIMUMAB-AATY | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | Interleukin-12 Antagonist [EPC] | 4 | 0.0000 |
| 3 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 4 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 | 0.0000 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |